Search
Three drugs target resistant breast cancers driven by HER2 mutations
https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-triple-therapy-her2.html
A targeted therapy using three different drugs significantly delayed progression and extended survival for breast cancer patients whose HER2 gene is mutated.
News Releases: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/?search=&phrase=Women's+Health&
Read past stories about the extraordinary work being done and the passionate people behind it.
News Releases: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/?phrase=zambia&search=&
Read past stories about the extraordinary work being done and the passionate people behind it.
Factors inherent to obesity could increase vulnerability to COVID-19: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/obesity-covid19.html
Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife.
UT Southwestern No. 1 hospital in Dallas-Fort Worth, Best Hospital rankings show: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-us-news-best-hospital.html?utm_source=facebook&utm_medium=organic&utm_campaign=newsroom&utm_content=usnwrrankings&utm_utm-audience=na&fbclid=IwAR3tY4r24j2gT-WKC5ar4jpT51bBLwVrirgZfpXOMV_c4aSikMhT6vdPJaI
UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – for the sixth consecutive year and ranks among the top hospitals nationally in nine specialties ranging from brain to heart to cancer care.
FDA-approved drugs could help fight COVID-19 - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/fda-approved-drugs-could-help-fight-covid19.html
Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting the new infection known as coronavirus disease 2019 (COVID-19)...
Drug targeting clear cell renal cell carcinoma shows promising approach: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-drug-targeting.html?fbclid=IwZXh0bgNhZW0CMTAAAR0qoz8aKfkpZ4rNlkoFjJ8sV79sQ2-f4lQZnwo4mrwmIuesBO1MZBeXY5k_aem_AW94ESPIrgDPqPPcOV5mP2WhgDKWR5Va4l6-c5sfofp7Ef5re9IgqYH2ny9w9W9k7N0tLdmNlrnLlDUk8umOFYRT
– In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells, ARO-HIF2, effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC).
Revised clinical trial rules during COVID-19 pandemic may benefit patients, survey shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/revised-clinical-trial-rules-during-covid-19.html
The COVID-19 pandemic has led to new rules and expectations for clinical trials.
Ticking time bomb: Malaria parasite has its own inherent clock: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/malaria-parasite-has-its-own-inherent-clock.html
The activity of the parasite that causes malaria is driven by the parasite’s own inherent clock.
Try physical therapy before your knee surgery: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/try-physical-therapy-before-your-knee-surgery.html
With knee replacement surgery becoming more common, Varatharaj Mounasamy, M.D., Professor of Orthopaedic Surgery at UT Southwestern Medical Center who specializes in hip and knee replacements, recommends taking off from work for a few weeks, joining a class to learn more about joint replacement, and